Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD-295 H5N1 Influenza Vaccine Phase II/III Study in Children and Adolescents
jRCT2080222578Phase 3Completed
- Sponsor
- KM Biologics
- Start
- Aug 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of KD-295 in influenza (2 arms), sponsored by KM Biologics. Started Aug 2014; status: completed.
02
Drugs
KD-295
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080222578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222578.